G. Waterer, Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia. », Archives of international medicine, pp.1837-1879, 2001.
DOI : 10.1001/archinte.161.15.1837

P. Houck, R. Maclehose, and M. Niederman, Empiric Antibiotic Therapy and Mortality Among Medicare Pneumonia Inpatients in 10 Western States, Chest, vol.119, issue.5, pp.1420-1426, 1995.
DOI : 10.1378/chest.119.5.1420

R. Brown, P. Iannini, and P. Gross, Impact of Initial Antibiotic Choice on Clinical Outcomes in Community-Acquired Pneumonia, Chest, vol.123, issue.5, pp.1503-1514, 2003.
DOI : 10.1378/chest.123.5.1503

W. Sligl, L. Asadi, D. Eurich, L. Tjosvold, T. Marrie et al., Macrolides and Mortality in Critically Ill Patients With Community-Acquired Pneumonia, Critical Care Medicine, vol.42, issue.2, pp.42-420, 2014.
DOI : 10.1097/CCM.0b013e3182a66b9b

M. Metersky, A. Ma, and P. Houck, Antibiotics for Bacteremic Pneumonia, Chest, vol.131, issue.2, pp.466-73, 2007.
DOI : 10.1378/chest.06-1426

L. Mandell, T. Marrie, R. Grossman, A. Chow, and R. Hyland, « Canadian guidelines for the initial management of community-­?acquired pneumonia: anevidence-­?based update by the